glp-1/gip dual agonist lilly orforglipron oral GLP-1 phase 3 weight loss trial GLP-1 Agonists in Cardiovascular Diseases:
Description
Studies on the Mechanism of Hormone Action
[DOI] [PubMed] [Google Scholar] 124.Durak A., Olgar Y., Degirmenci S., Akkus E., Tuncay E., Turan B
Regular physical activity can also contribute to a healthy lifestyle
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
doi: 10.1172/jci.insight.140532 [DOI] [PMC free article] [PubMed] [Google Scholar] 228.Liu QK
